AGIO vs PODD · rev $65.5M vs P/E 34, rev $1.56B
Agios Pharm (AGIO) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported PODD revenue for 2026-06-30 was $1.56B. Net income was $186.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
AGIO currently screens at market cap $1.68B. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the AGIO and PODD stock pages for the full models.
Not investment advice.